Skip to main content
Premium Trial:

Request an Annual Quote

Sense Biodetection: Timothy Still

Sense Biodetection has appointed Timothy Still as president and CEO. He also will serve on the company's board. Harry Lamble, the former CEO and cofounder of Sense will remain with the firm as chief business development officer. Still has more than 30 years of experience in the medical devices and diagnostics industries, including as chairman and CEO of consulting firm TStill Enterprises, according to LinkedIn. He has also been a non-executive board member of MDxHealth. Boston-based Sense develops instrument-free, rapid molecular tests. Its Veros platform delivers PCR-quality lab results within minutes without an instrument, according to the company.

The Scan

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.

Effectiveness May Decline, Data From Israel Suggests

The New York Times reports that new Israeli data suggests a decline in Pfizer-BioNTech SARS-CoV-2 vaccine effectiveness against Delta variant infection, though protection against severe disease remains high.

To See Future Risk

Slate looks into the use of polygenic risk scores in embryo screening.

PLOS Papers on Methicillin-Resistant Staphylococcus, Bone Marrow Smear Sequencing, More

In PLOS this week: genomic analysis of methicillin-resistant Staphylococcus pseudintermedius, archived bone marrow sequencing, and more.